BLOOD MOLECULAR BIOLOGY TUBES MARKET ANALYSIS

Molecular biology is the study of the molecular foundation of biological activity amongst biomolecules in a variety of systems of a cell, including DNA, RNA, and proteins interactions and their biosynthesis. It also tells us about the directive for these interactions. Molecular diagnostics is a set of procedures used to examine biological markers (an assessable pointer of a biological condition or state) in the genome or genetic makeup of an organism and proteome or the group of proteins expressed by the genetic makeup. Molecular diagnostics are performed by applying molecular biology to therapeutic diagnosis. The practice is used to detect and monitor disease, diagnose risk, and decide the specific therapies for specific patients. By examining the particulars of the patient, molecular diagnostics suggests personalized medicines for specific disease the patient is suffering from. These diagnostic tests are helpful for an array of medical areas, including oncology, infectious diseases, immune function disorders, coagulation, and pharmacogenomics—projection of which medication will work best. Blood molecular biology tubes are used specifically for collecting blood for molecular diagnosis.

Molecular biology is essential both to the patients and the researchers alike. Patients are diagnosed on the basis of their genetic makeup or diseases related to their disorientation or mutation. Researchers use them for performing various experiments. For both the abovementioned cases, blood molecular biology tubes are widely used. As scientific research is scaling new heights, demand for blood molecular biology tubes is consequently projected to rise at a considerable rate. Molecular biology tests are performed for various purposes such as to establish interaction between blood group molecules and to determine acute and chronic leukemia. Chronic leukemia may not be noticed by any symptoms until a blood molecular biology test is performed. According to World Cancer Research Fund International, an estimated 14.1 million people around the world suffered from cancer in 2012; out of these 7.4 million were men and 6.7 million women. The total number of reported incidence is likely to touch around 24 million by 2035, an increase of around 70.0%. As the population around the world is becoming aware of such incidences and the method for their diagnosis and early prevention, the need for blood molecular biology tests is expected to increase manifolds. This in turn would argue well for overall growth of the blood molecular biology tubes market.

Blood Molecular Biology Tubes Market Taxonomy

On the basis of techniques used the global market is classified into:

• Molecular cloning
• Polymerase chain reaction (PCR)
• Gel electrophoresis
• Macromolecule blotting and probing
• Microarrays

On the basis of type of end user the global market is classified into:

• Hospitals
• Diagnostic Centre
• Research Laboratories
• Others

As per the National Centre for Biotechnology Information, blood molecular biology test is perhaps the area of laboratory medicine that is growing at a considerable rate and it has the prospect for a major effect on medical field within the next ten years. As blood molecular biology test areas develop, so will the perspective of how structural dissimilarities in RNA and DNA are linked with the advancement of chronic diseases. New and advanced technologies have added to the spectacular speed with which the genetic mechanisms of diseases are investigated. Future progress in this area would be propelled by enhancement in science and technology and the accessibility to carefully documented and acknowledged study populations. This creates a highly conducive environment for growth of the blood molecular biology tubes market.

Technological advancement and increase in genetic disorders to argue well for blood molecular biology tubes market growth

Molecular biology tests helps monitor diseases more accurately, determine the most appropriate treatment, and reduce patient morbidity and mortality. They are essential for diagnosis, treatment and control of infectious diseases such as microbial infections. According to the World Health Organization, the number of deaths caused by pathogens and parasites is likely to reach 13 million by 2050. Early detection and prevention of these diseases has been gaining traction in the present scenario, thereby offering significant avenue for growth of the blood molecular biology tubes market.

Some of the companies operating in the global blood molecular biology tubes industry are BD, Greiner, Ajosha Bio Teknik Pvt. Ltd., Narang Medical Limited., Goldwin Medicare Ltd., Beijing Hanbaihan Medical Devices Co., Ltd. and Gosselin.

Key Developments

1. Major companies in the market are focused on various business strategies such as gaining product approval from regulatory authorities, in order gain competitive edge in the market. For instance, in February 2018, Becton, Dickson and Company received CE-IVD marking for its PAXgene Blood ccfDNA tube, which is commercially available in Western Europe.
2. Key players in the market are focused on various business strategies such as product launches, in order to expand their product portfolio and enhance the market presence. For instance, in February 2019, Greiner Bio-One, an Austria-based biotechnology device manufacturer, launched the new VACUETTE SAFELINK Holder. This is a sterile tube holder, which provides a safe, needless option for blood collection.
3. Key companies in the market are involved in various business strategies such as product launches, in order to expand their product portfolio and gain competitive edge in the market. For instance, Greiner Bio-One launched MiniCollect K2EDTA Capillary Collection Tube. These capillary tubes are designed to collect and transport blood samples with sterile environment.